Key result
Low-intensity training with blood flow restriction substantially improves lower-limb strength versus controls.
Why the study?
Low-intensity resistance training with blood flow restriction may improve musculoskeletal function, but its effects in musculoskeletal disorders remain uncertain.
Does low-intensity resistance training with blood flow restriction improve lower-limb muscle function and mobility in adults with musculoskeletal disorders?
Meta-Analysis (n=638)
Does low-intensity resistance training with blood flow restriction improve lower-limb muscle function and mobility in adults with musculoskeletal disorders?
Standardized Mean Difference: 1.2 (95% CI 0.54–1.87)
LIRT-BFR improves lower-limb muscle strength, size, and functionality compared to non-exercise controls in adults with musculoskeletal disorders, with some benefits over LIRT alone but no advantage over MHIRT.
Supports LIRT-BFR as a viable alternative to moderate-to-high intensity training in musculoskeletal disorders; extends RCT evidence to clinical populations unable to tolerate higher loads.
BackgroundLow-intensity resistance training with blood flow restriction (LIRT-BFR) may improve musculoskeletal function, but its effects in musculoskeletal disorders remain uncertain.ObjectiveTo examine LIRT-BFR effects on lower-limb muscle size, strength, and mobility in musculoskeletal disorders, and explore potential effect modifiers.MethodsFive databases (PubMed, Cochrane Library, Web of Science, SPORTDiscus, EMBASE) were searched from inception to November 20, 2025. Randomized controlled trials involving adults with musculoskeletal disorders comparing LIRT-BFR to control or active interventions were included. Two reviewers independently screened studies and extracted data. Random-effects meta-analyses were conducted, and certainty of evidence was assessed using the GRADE approach.ResultsSixteen trials (638 participants) were included. Compared with non-exercise controls, LIRT-BFR significantly improved lower-limb muscle strength (g = 1.20, 95% CI [0.54, 1.87]), muscle size (g = 1.65, 95% CI [0.88, 2.43]), and lower-limb functionality (TUG: g = -0.73, 95% CI [-1.21, -0.24]; TST: g = 1.85, 95% CI [1.19, 2.52]). Compared with LIRT alone, LIRT-BFR improved muscle strength (g = 0.56, 95% CI 0.08-1.04) and timed-stands performance (g = 0.86, 95% CI 0.44-1.28). No advantage over MHIRT was observed for muscle strength (g = -0.10, 95% CI -0.48 to 0.28) or timed-stands performance (g = -0.50, 95% CI -1.01 to 0.01). Exploratory analyses showed favorable point estimates for 12-18 sessions and non-failure protocols. Certainty of evidence ranged from moderate to very low across comparator-specific outcomes.ConclusionsLIRT-BFR improves lower-limb muscle and functional outcomes relative to non-exercise controls and may provide additional benefits over LIRT for selected outcomes. No advantage over MHIRT was identified. Clinical heterogeneity, wide prediction intervals, and risk of bias warrant cautious interpretation.
No takes yet. Share an insight, caveat, or question.
Tan et al. (2026) conducted a meta-analysis in Musculoskeletal disorders (n=638). Low-intensity resistance training with blood flow restriction (LIRT-BFR) vs. Non-exercise controls, LIRT alone, or MHIRT was evaluated on Lower-limb muscle strength (vs non-exercise controls) (g 1.20, 95% CI 0.54-1.87). Low-intensity resistance training with blood flow restriction improved lower-limb muscle strength compared with non-exercise controls (SMD 1.20; 95% CI 0.54-1.87).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: